Long-Term Effectiveness and Safety of Sirolimus Stent Implantation for Coronary In-Stent Restenosis. Results of the TRUE (Tuscany Registry of Sirolimus for Unselected In-Stent Restenosis) Registry at 4 Years

Journal of the American College of Cardiology

Volumn 55, Issue 7, 2010, Pages 613-616

  Liistro, Francesco ^a   Fineschi, Massimo ^b   Grotti, Simone ^a   Angioli, Paolo ^a   Carrera, Arcangelo ^b   Ducci, Kenneth ^a   Gori, Tommaso ^b   Falsini, Giovanni ^a   Pierli, Carlo ^b   Bolognese, Leonardo ^a  

^a IRCCS POLICLINICO SAN DONATO   (Italy)

^b UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

in stent restenosis; late stent thrombosis; long term clinical outcome; sirolimus eluting stent

Indexed keywords

RAPAMYCIN;

ARTICLE; CLINICAL TRIAL; CORONARY STENT; DRUG EFFECT; DRUG ELUTING STENT; DRUG SAFETY; EVENT FREE SURVIVAL; HEART DEATH; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; RESTENOSIS; REVASCULARIZATION; STENT THROMBOSIS; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ASPIRIN; CARDIOVASCULAR AGENTS; CORONARY RESTENOSIS; CORONARY THROMBOSIS; CREATININE; DIABETES MELLITUS; DRUG-ELUTING STENTS; FOLLOW-UP STUDIES; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; REGISTRIES; SIROLIMUS; STROKE VOLUME; TICLOPIDINE;

EID: 76449109817     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.08.075     Document Type: Article

References (13)

1. Alfonso F., Perez-Vizcayno M.J., Hernandez R., et al., RIBS-II Investigators. A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) trial. J Am Coll Cardiol 47 (2006) 2152-2160
2. Dibra A., Kastrati A., Alfonso F., et al. Effectiveness of drug-eluting stents in patients with bare-metal in-stent restenosis: meta-analysis of randomized trials. J Am Coll Cardiol 49 (2007) 616-623
3. Ellis S.G., O'Shaughnessy C.D., Martin S.L., et al., TAXUS V ISR Investigators. Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial. Eur Heart J 29 (2008) 1625-1634
4. Holmes Jr. D.R., Teirstein P.S., Satler L., et al., SISR Investigators. 3-year follow-up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) trial. J Am Coll Cardiol Intv 1 (2008) 439-448
5. Camenzind E., Steg P.G., and Wijns W. Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern. Circulation 115 (2007) 1440-1455 discussion 1455
6. Daemen J., Wenaweser P., Tsuchida K., et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 369 (2007) 667-678
7. Ellis S.G., Colombo A., Grube E., et al. Incidence, timing, and correlates of stent thrombosis with the polymeric paclitaxel drug-eluting stent: a TAXUS II, IV, V, and VI meta-analysis of 3,445 patients followed for up to 3 years. J Am Coll Cardiol 49 (2007) 1043-1051
8. Jaffe R., and Strauss B.H. Late and very late thrombosis of drug-eluting stents: evolving concepts and perspectives. J Am Coll Cardiol 50 (2007) 119-127
9. Liistro F., Fineschi M., Angioli P., et al. Effectiveness and safety of sirolimus stent implantation for coronary in-stent restenosis: the TRUE (Tuscany Registry of Sirolimus for Unselected In-Stent Restenosis) Registry. J Am Coll Cardiol 48 (2006) 270-275
10. Cutlip D.E., Windecker S., Mehran R., et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115 (2007) 2344-2351
11. Mauri L., Hsieh W.H., Massaro J.M., Ho K.K., D'Agostino R., and Cutlip D.E. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 356 (2007) 1020-1029
12. Waksman R., Ajani A.E., White R.L., et al. Five-year follow-up after intracoronary gamma radiation therapy for in-stent restenosis. Circulation 109 (2004) 340-344
13. Migliorini A., Shehu M., Carrabba N., et al. Predictors of outcome after sirolimus-eluting stent implantation for complex in-stent restenosis. Am J Cardiol 96 (2005) 1110-1112